SOURCE: Milken Institute

Milken Institute

June 26, 2014 09:00 ET

Science Translational Medicine Focuses on Emergence of Consortia in Medical Research

WASHINGTON, DC--(Marketwired - Jun 26, 2014) -  A study published in the June 25 issue of Science Translational Medicine found that in the past decade, there has been a rapid emergence of consortia in biomedical research. The study, Consortium Sandbox, noted that this trend is in response to the growing need for broad-based partnerships to address shared scientific, regulatory, or reimbursement challenges.

Mark Lim, associate director of medical innovation at FasterCures and author of the study analyzed the characteristics of 369 consortia from around the world and found that these efforts provide a safe harbor for participants by guaranteeing transparency and equitable access to any outputs. Lim defines consortium efforts as public-private partnerships built on a framework that provides neutral and temporary collaborative environments for several, often times competing, organizations.

Lim found that this type of collaboration is uniquely designed to allow for careful monitoring, course correction, and cross-sector validation in the development of new research tools and resources.

This study builds upon FasterCures' Consortia-pedia program focused on the emerging model of research collaboration-by-consortium and its impact on medical research and development.

More information, including a copy of the paper can be found at http://stm.sciencemag.org/content/6/242/242cm6.

To learn more about FasterCures' Consortia-Pedia Program, visit http://consortiapedia.fastercures.org/

FasterCures, a Center of the Milken Institute, is a nonprofit, nonpartisan action tank that works to speed and improve the medical research system across sectors and diseases.  For more information, visit www.fastercures.org

Contact Information